Tovo-Rodrigues, Luciana http://orcid.org/0000-0002-8732-6059
Schneider, Bruna Celestino
Martins-Silva, Thais
Del-Ponte, Bianca
Loret de Mola, Christian
Schuler-Faccini, Lavinia
Vianna, Fernanda Sales Luiz
Munhoz, Tiago N.
Entiauspe, Ludmila
Silveira, Mariângela Freitas
Santos, Iná S.
Matijasevich, Alicia
Barros, Aluísio J. D.
Rohde, Luis Augusto
Bertoldi, Andréa Dâmaso
Funding for this research was provided by:
Wellcome Trust
World Health Organization
National Support Program for Centers of Excellence
Brazilian National Research Council
Brazilian Ministry of Health
Children’s Pastorate
Brazilian National Council for Scientific and Technological Development (400943/2013-1)
São Paulo Research Foundation—FAPESP (2014/13864-6)
Article History
Received: 5 July 2018
Accepted: 25 October 2018
First Online: 20 November 2018
Ethics approval and consent to participate
: The Medical Ethics Committee of the Federal University of Pelotas approved the study protocol and all follow-ups of the Pelotas 2004 Birth Cohort Study. Mothers signed a consent form on behalf of them and their children at each follow-up, after being informed of the study objectives. At the 11-year follow-up, the cohort participants aged 11 years or more also signed an informed consent form.
: Not applicable
: LAR has been a member of the speakers’ bureau/advisory board and/or acted as a consultant for Eli-Lilly, Janssen-Cilag, Medice, Novartis and Shire in the last three years. He receives authorship royalties from Oxford Press and ArtMed. He has also received travel awards from Shire for his participation in the 2018 APA meetings and from Novartis to take part of the 2016 AACAP meeting. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Janssen - Cilag, Novartis, and Shire.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.